Drugs / 10-valent pneumococcal conjugate vaccine
10-valent pneumococcal conjugate vaccine
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00307567 | Nov 2005 → Mar 2006 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, poliomyelitis +1 | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT00370227 | Oct 2006 → Mar 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00307034 | Jan 2006 → Jan 2007 | streptococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT00307541 | Oct 2005 → Apr 2006 | pneumococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
| Comparator or background therapy2 trials | ||||||
| Phase 3 | NCT00370318 Background | Sep 2006 → Apr 2007 | Rotavirus infection | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT02385513 Comparator | Aug 2015 → Jan 2017 | pneumococcal infection | University of Oxford | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 7 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 10-valent pneumococcal conjugate vaccine | “Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine” NCT00370227 ↗5“10V group: GSK Biologicals' 10-valent pneumococcal conjugate vaccine + DTPa-HBV-IPV/Hib” NCT00307567 ↗ “GSK Biologicals' 10-valent pneumococcal conjugate vaccine” NCT00307541 ↗ |
| Known as | PCV10 | “Nepalese infants receive ten-valent pneumococcal conjugate vaccine (PCV10) with a 1 month interval between priming doses for programmatic reasons.” PMID 30635252 ↗ Jan 2019 |
| Known as | pneumococcal conjugate vaccine | “This study will evaluate the safety, reactogenicity and immunogenicity of a booster dose of the pneumococcal conjugate vaccine” NCT00370227 ↗ |
| Modality | Vaccine | “10-valent pneumococcal conjugate vaccine” NCT00307034 ↗ |
| Route | Intramuscular | “Intramuscular injection, 3 or 4 doses (2-4-11 or 2-3-4-11 months of age schedule).” NCT00307034 ↗ |